Biotech Startup Nabs $42M to Develop Cancer Drugs - Oct. 11, 2011

Having trouble viewing this email? View in Browser.

Tuesday, October 11, 2011  |   |   |   |  CHI's 11 Annual PepTalk: The Protein Science WeeK January 9-13, 2012 | Hotel Del Coronado | San Diego, CA www.chi-peptalk.com REGISTER BY FRIDAY, October 14 and SAVE UP TO $400! PepTalk 2012 continues the tradition of strong scientific programming centered around protein-based therapeutics. The four distinct protein pipelines focused on formulation, purification, biotherapeutics and expression range from applying protein discovery research, to developing downstream protein products that ultimately lead to clinical applications. Create your own agenda by moving between the tracks and choosing the sessions that best fit your research and networking needs. Please click here for more information.   •  Biotech Startup Nabs $42M to Develop Cancer Drugs More... •  GlycoMimetics, Inc. Inks Licensing Deal Worth Up to $340 Million with Pfizer Inc. (PFE) More... •  Rosetta Genomics Ltd. (ROSG) to Slash 35 Jobs to Focus on MDx Commercialization in the U.S. More... •  Bristol-Myers Squibb Company (BMY)'s Sprycel May Increase Hypertension Risk, FDA Says More... •  Roche (RHHBY)'s Experimental Alzheimer's Drug Gantenerumab Looks Promising in Phase I More... •  Anteco Pharma to Expand Lodi Plant, 60 New Pharma/Medical Device Jobs More... •  Biostar Pharmaceuticals, Inc. (BSPM) Signs Agreement to Acquire Shaanxi Weinan Huaren Pharmaceuticals, Ltd. for $9.62 Million More... •  Azelon Pharmaceuticals Secures $4.5 Million in Series A Financing to Support Phase 2 Study of Nasal Spray Teriparatide (PTH1-34) for the Treatment of Osteoporosis More... More Top News BASF Custom Synthesis BASF offers exclusive development and manufacturing services for active ingredients and advanced intermediates. Our team of experts provides support throughout the drug lifecycle - from the early clinical phase, through the exclusivity period, and later during the generic phase of a drug life cycle. For more information, please visit: www.custom-synthesis.basf.com. •  GlaxoSmithKline (GSK) Scientists Brush Up on Sales Pitches More... •  Karolinska Institute Study: Chocolate Lovers Have Lower Risk of Stroke More... •  Dietary Supplements Risky for Older Women, University of Minnesota Study More... •  Restless Legs Syndrome May Raise High Blood Pressure Risk in Middle-Aged Women, Brigham and Women's Hospital Study More... •  Diabetes Reversed in Mice, All Naturally, Washington University Study More... •  Obese Mothers Put Children At Higher Risk of Asthma, Murdoch Childrens Research Institute and University of Melbourne Study More... •  After Stroke, Crossed Legs a Welcome Sign, University of Munich Study More... •  Self-Awareness Cells in Brain Linked to Alzheimer's Symptoms, University Hospital Schleswig-Holstein Reveals More...   More Featured News IBC's BioProcess International Conference & Exhibition October 31 - November 4, 2011 - Long Beach, California Event Website Download the 2011 BioProcess International brochure and see why this is YOUR must attend event for 2011. Download your PDF here. You will see the 2011 program, features a stellar line up keynote presentations including, the US FDA, EMA, Pfizer, Merck and more. Plus, there are over 50 presentations with new, previously unpublished data, and new topic coverage areas including antibody drug conjugates, viral clearance and managing global manufacturing facilities and partners. Exhibit hall & keynote passes are now available. Mention priority code B11171BSEODS2 and the fee will be waived. All passes subject to approval. Register here today or call 800-390-4078. The Hepatitis Market Outlook to 2016 • Understand how recent events are affecting the performance of major products, and how their marketers are confronting competitive market changes. • Compare the franchises of the leading companies in the hepatitis market, and understand how the market share of these companies will change. • Evaluate pipeline compounds for the treatment of hepatitis and determine which products will provide the greatest revenue growth. • Understand the market dynamics and interactions between the key drug classes used in the treatment of hepatitis. Click Here for More Information. Drug Discovery & Development Drug Discovery & Development magazine delivers vital insight about the latest technologies and tools used to develop pharmaceutical products to key decision-makers Request Now! • BioMidwest (Madison, Wisconsin) Promega Corporation Director, Process Development We are seeking a Director of Process Development to join our Operations Division. This role will be part of a dynamic team providing technical support for upstream and downstream processing, which includes a strong research pipeline that demands rapid development and tech transfer to production environments. • Pharm Country (Radnor, Pennsylvania) PolyMedix, Inc. Clinical Trial Operations Manager/Director Experience in execution of Phase II Phase II pivotal studies, Phase III and small Phase I studies and larger, multi-center trial management. Experience in infectious diseases and/or cardio vascular. Well versed in GCP and applicable FDA/EMEA regulations required. Ability to prepare and present clinical trial updates to senior management. • Biotech Bay (South San Francisco, California) Genentech, Inc Scientist / Senior Scientist, Analytical Chemistry Will be responsible for the life cycle management of Genentech's entire biotech commercial quality control methods, control systems/specifications and assay transfers. He/ she will be accountable for global assay troubleshooting and optimization; assay development, validation and comparability studies; investigations and CAPAs across Genentech's entire commercial biotech testing sites (including CMOs and partners). • Biotech Beach (San Diego, California) Synteract, Inc. Regional Clinical Research Associate Will assist in all aspects of clinical trials management, including initiating, investigating and monitoring of clinical studies. Position will be regional and home-based. • Bio NC (Northcove, North Carolina) Baxter International, Inc. Supervisor I, Manufacturing Responsible for implementing and supervising daily maintenance activities in a specific production area to ensure manufacturing goals and project deadlines are met while maintaining compliance with current good manufacturing practices (GMPs), environmental health and safety (EHS) guidelines and any other regulations that could apply. Get Noticed! Add your resume to the BioSpace Career Center! See more than 5,000 job postings in the BioSpace Career Center! Biotech Bay Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Bay area region. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • Biotech Bay Career Fair, Burlingame, CA October 11, 2011 • Bio NC Career Fair, Durham, NC October 20, 2011 • BioCapital Beach Career Fair, Bethesda, MD November 1, 2011 • Genetown Career Fair, Cambridge, MA November 7, 2011 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services InterMune, Inc. 3280 Bayshore Boulevard Brisbane California 94005 U.S.A. Phone: 415-466-2200 Fax: 415-466-2329 InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and hepatology. InterMune has a product portfolio addressing IPF and HCV infections. . The pulmonology portfolio includes Actimmune®, which is being evaluated in the INSPIRE Trial, a Phase III study in patients with IPF, and pirfenidone, which is also being developed for the treatment of IPF. More Company Profiles FREE Subscription to Medical Product Outsourcing Their in-depth coverage includes comprehensive feature articles, industry news, trends and other developments pertinent to the CM-OEM relationship. Medical Product Outsourcing examines the increasingly complex and demanding requirements of managing outsourcing partnerships. Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship BioSpace Inc. 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 BioSpace Inc. 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the BioSpace News Beat Team. Editor & Publisher: Rosemary Do Editorial & Production Staff: Lana Ho, Suvarna Sheth, Maysa Darwish, Tammy Liu BioSpace.com - Life. Science. Community. • BioSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2011 BioSpace http://www.biospace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.